3 hours Cytokinetics, Incorporated (NASDAQ:CYTK) Director Wendall Wierenga Sells 4,452 SharesMarketBeat
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Wendall Wierenga sold 4,452 shares of the company’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $52.25, for a total value of $232,617.0…
X